Collectively, the data demonstrate that GSDMD deletion re-calibrates macrophage activation toward an anti-inflammatory phenotype and thereby mitigates BPD-associated pulmonary inflammation. The gene discussed is GSDMD; the disease is bronchopulmonary dysplasia.